Sensei Biotherapeutics, Inc. (SNSE) Financials
SNSE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 74.4 million | 9.5 million |
2023-09-30 | 81.7 million | 10.7 million |
2023-06-30 | 89.6 million | 10.4 million |
2023-03-31 | 107.9 million | 13.1 million |
SNSE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.2 million | 1.1 million |
2023-09-30 | -4.7 million | 1.0 million |
2023-06-30 | -9.5 million | 1.1 million |
2023-03-31 | -11.9 million | 1.2 million |
SNSE Net Income
No data available :(
SNSE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 65.8 million | - | 6.2 million |
2023-09-30 | 72.0 million | - | 6.8 million |
2023-06-30 | 78.8 million | - | 7.3 million |
2023-03-31 | 8.1 million | - | 7.8 million |
SNSE Shares Outstanding
SNSE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 4.5 million | 3.6 million | 135000 |
2023-09-30 | - | 3.8 million | 3.9 million | - |
2023-06-30 | 29000 | 4.8 million | 5.4 million | - |
2023-03-31 | 151000 | 5.2 million | 5.8 million | - |
SNSE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 2.8 million | 135000 |
2023-09-30 | - | 455000 |
2023-06-30 | - | 491000 |
2023-03-31 | - | 477000 |
SNSE
Price: $1.75
52 week price:
Earnings Per Share: -1.22 USD
P/E Ratio: -0.61
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 18884
Market Capitalization: 27.9 million